Oral Contraceptive Hormone-free Interval Pituitary/ Ovarian Activity
NCT ID: NCT01953211
Last Updated: 2019-07-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
64 participants
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oral Contraceptive Therapy and Sexuality
NCT02613039
The Effects of Continuous Administration of a Monophasic Oral Contraceptive on Bleeding Days and Endometrial and Ovarian Function
NCT00128726
Quality of Life During Different Regimens of Combined Hormonal Contraceptives in Women of Reproductive Age
NCT06918873
A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens
NCT00117273
A Study to Evaluate Inhibition of Ovulation of Two Oral Estrogen/Progestogen Regimens in Healthy, Young Females Over a Period of 3 Treatment Cycles
NCT00631124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy reproductive age women
These volunteers were previously taking the oral contraceptives of interest for a minimum of 3 months
combined oral contraceptives
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
combined oral contraceptives
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 to 35 years old,
* seeking contraception from the general gynecology clinics of the LAC and USC Medical Center w
* taking one of 6 possible monophasic COC formulations for at least 3 cycles prior to enrollment
* regular menstrual cycles prior to COCs
Exclusion Criteria
* bilateral oophorectomy
* amenorrhea
* hormone-sensitive cancer
* concurrent medications known to interfere with steroid metabolism (i.e., barbiturates, phenytoin, carbamazepine, ethosuximide, primidone, rifampin, tetracycline)
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Southern California
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frank Stanczyk
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
LAC and USC Medical Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Hormone free interval
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.